Sermorelin
Sermorelin (GRF 1-29) is a synthetic GHRH-analogue peptide that stimulates the pituitary to release growth hormone in natural, pulsatile rhythm.
1 vial · 5 mg total
Checking availability…
Total Price
฿800
Prefer Revolut, Wise or PayPal?
For research & laboratory use only. Not for human consumption.
Shipping: free within Thailand, ฿700 worldwide. Added at checkout. Delivery times & countries
Half-Life
~7-12 minutes
Administration Route
Subcutaneous injection
Natural GHRH Sequence
First 29 amino acids of endogenous growth hormone-releasing hormone
Hypothalamic Feedback
Preserves natural GH axis; avoids pituitary suppression
Anti-Aging HGH
Restores youthful GH output in age-related decline
Mechanism of Action
Scientific Research
Biochem Biophys Res Commun (1984)
Why Researchers Choose Sermorelin
Sermorelin is the GHRH(1-29) peptide with the deepest pharmacological literature, which makes it the reference secretagogue whenever a study needs a physiological growth-hormone stimulus rather than exogenous HGH. Common research directions include:
- GHRH-receptor signalling and pituitary somatotroph responsiveness
- Pulsatile versus continuous GH-release dynamics
- Age-related GH decline (somatopause) and the aging GH axis
- Body-composition models (lean mass, fat distribution)
- Sleep-related GH secretion, since the largest GH pulse follows slow-wave sleep onset
- Benchmarking against modified analogues such as CJC-1295 and tesamorelin
Why the GHRH(1-29) Fragment is Enough
Native GHRH is 44 amino acids long, but its activity is concentrated in the N-terminal segment:
- Residues 1-29: receptor binding and full biological agonist activity
- Residues 30-44: dispensable for receptor activation, with a possible role in molecular stability
Because the 1-29 fragment retains full potency at the GHRH receptor, sermorelin behaves as a functional equivalent of full-length GHRH while being far simpler to synthesise as a research peptide.
Pulsatile Release and Somatostatin Feedback
The short ~7-12 minute half-life is a feature, not a limitation: it lets sermorelin operate inside the natural hypothalamic-pituitary rhythm.
- The hypothalamus normally releases GHRH in pulses across the day
- Between pulses, somatostatin (SRIF) tone suppresses GH release
- Sermorelin, like native GHRH, acts mainly during the low-somatostatin windows
- The result is a preserved pulsatile GH pattern, which matters for receptor sensitivity and anabolic signalling
Long-acting GHRH analogues with multi-day half-lives instead produce more continuous GH elevation that overrides this inhibitory rhythm.
Clinical Background
Sermorelin was marketed as Geref (Serono) and used for GH-provocation testing and for idiopathic GH deficiency in children. Subsequent investigational work in adults has explored its effects on somatopause, body composition, and sleep-dependent GH output, building the long track record that distinguishes sermorelin from newer GHRH analogues.
Reconstitution and Storage
Reconstitution: use bacteriostatic water; swirl gently until dissolved, do not shake. After reconstitution: store refrigerated and use within 2 to 3 weeks; protect from light.
For research purposes only. Not for human consumption.
Further Reading
Vial & calculation
Calculate concentration and volume from the labelled amount, your final solution volume and a target amount you provide.
Open calculator for SermorelinCurrent product variants are listed in the calculator. No personal dose is selected for you.
Product FAQs
Stacks Well With
Related Products
CJC-1295 (no DAC)
CJC-1295 without DAC (Mod GRF 1-29) is a short-acting GHRH analogue that triggers pulsatile growth hormone release for muscle, recovery and fat-loss research.
Ipamorelin
Ipamorelin is a selective pentapeptide growth hormone secretagogue (GHRP) that triggers clean, pulsatile GH release without spiking cortisol or prolactin.
Tesamorelin
Tesamorelin (Egrifta) is an FDA-approved GHRH(1-44) analogue that stimulates natural growth hormone release to drive visceral fat loss and IGF-1 production.